Search Within

Marcel R M Van Den Brink

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (341)
  2. Journal Article (247)
  3. Review (12)
  4. Research Letter (5)
  5. Correspondence (4)
  6. Editorial (3)
  7. Book Section (2)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (616)
  2. Department of Medicine (616)
  3. Executive Committee, Center for Hematologic Malignancies (616)
  4. GSK Faculty (616)
  5. Hematologic Malignancies, Division of (616)
  6. Immunology Program Faculty (616)

More Groups

People
  1. Miguel-Angel Perales (174)
  2. Sergio Giralt (131)
  3. Jonathan Peled (121)
  4. Odette Smith (95)
  5. Robert Jenq (94)
  6. Doris Ponce (90)

More People

Years
  1. 2025 (1)
  2. 2024 (15)
  3. 2023 (36)
  4. 2022 (29)
  5. 2021 (25)
  6. 2020 (29)

More Years

Publications
  1. Blood (211)
  2. Biology of Blood and Marrow Transplantation (127)
  3. Bone Marrow Transplantation (29)
  4. Journal of Immunology (18)
  5. Journal of Clinical Oncology (12)
  6. Journal of Clinical Investigation (9)

More Publications

Publishers
  1. American Society of Hematology (218)
  2. Elsevier Inc. (150)
  3. Nature Publishing Group (73)
  4. The American Association of Immunologists, Inc (18)
  5. Cell Press (16)
  6. American Association for Cancer Research (12)

More Publishers

Results (616)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IL-22 administration protects intestinal stem cells from GVHD
    Meeting Abstract

    Lindemans, C.; Mertelsmann, A.; Dudakov, J. A.; Velardi, E.; Hua, G. Q.; O'connor, M.; Kolesnick, R.; van den Brink, M. R. M.; Hanash, A. M.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Identification of intestinal commensal bacteria protective against GVHD in mice and humans
    Meeting Abstract

    Jenq, R.; van den Brink, M. R. M.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers
    Journal Article

    Ghosh, A.; Holland, A. M.; van den Brink, M. R. M.
    Immunological Reviews (2014)

    Fulltext@MSK | Save
  • Sex steroid blockade enhances thymopoiesis by modulating notch signaling
    Meeting Abstract

    Velardi, E.; Tsai, J. J.; Holland, A. M.; Singer, N. V.; West, M. L.; Smith, O. M.; Young, L. F.; Kreines, F. M.; Levy, E. R.; Boyd, R.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Comprehensive mutational profiling in myelodysplastic syndromes treated with decitabine and tretinoin
    Meeting Abstract

    Shih, A. H.; Devlin, S. M.; Dolezal, E. K.; Knapp, K. M.; Wang, K.; Sanford, E. M.; Brennan, T.; Yelensky, R.; Nahas, M.; Otto, G. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS
    Meeting Abstract

    Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • IL-22 administration decreases intestinal GVHD pathology, increases intestinal stem cell recovery, and enhances immune reconstitution following allogeneic hematopoietic transplantation
    Meeting Abstract

    Mertelsmann, A. M.; Dudakov, J. A.; Velardi, E.; Hua, G.; Kreines, F. M.; Levy, E. R.; O'Connor, M.; Smith, O. M.; Kolesnick, R.; van den Brink, M. R. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma
    Meeting Abstract

    Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations in hematologic malignancies by a clinical next generation sequencing-based assay
    Meeting Abstract

    Lipson, D.; Nahas, M. K.; Otto, G. A.; Yelensky, R.; Abdel-Wahab, O.; Wang, K.; He, J.; Intlekofer, A. M.; Rampal, R. K.; Brennan, T. A.; more...
    Blood (2013)

    Fulltext@MSK | Save